The workshop is done in collaboration with ISPE Singapore and will cover the following points stated on the below section.
Details will be provided on:
- Current debates in the industry regarding disinfectant coupon testing.
- PDA Technical Report No. 70 and USP 43 <1072> in relation to current industry disinfectant efficacy testing.
- Recent FDA Warning Letters and 483s highlighting regulator expectations in disinfectant efficacy testing.
- Data will be presented on the importance of disinfectant efficacy testing with specific bacterial spores which can be more difficult to kill than ATCC strains.
- Both sides of the debate on disinfectant validation detailed with emphasis on current FDA, MHRA, ANVISA, ANSM, CFDA, and HPRA regulatory expectations and reducing the costs for testing.
Led by STERIS Expert:
Pedro Lopez, Product Manager at STERIS Corporation
